Lantz Medical Competitors and Similar CompaniesClear all

Lantz Medical's competitors and similar companies include Midmark, Richard Wolf, Zhejiang Gongdong Medical Technology and Nipponflex.

	Lantz Medical Lantz Medical is a company that manufactures and distributes a range of motion (ROM) and physical rehabilitation products.	Midmark Midmark is a company that manufactures and supplies medical, dental, and veterinary equipment.	Richard Wolf Richard Wolf is a supplier of products and solutions for endoscopy and extracorporeal shock wave treatment.	Zhejiang Gongdong Medical Technology Zhejiang Gongdong Medical Technology is a manufacturer and supplier of medical devices and supplies.	Nipponflex Nipponflex is a company that specializes in the development of the scientific sleeping system.
Founding Date	Founding Date 2005	Founding Date 1915	Founding Date 1906	Founding Date 1985	Founding Date 1987
Type	Type Private	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare medical devices	Tags Healthcare dental ecommerce medical devices veterinary	Tags Healthcare medical devices	Tags Healthcare medical devices	Tags Healthcare medical devices
Locations	Locations Indianapolis, US HQ	Locations Versailles, US HQ Brisbane City, AU Melbourne, AU Perth, AU Sydney, AU Bruxelles, BE São Paulo, BR see more	Locations Knittlingen, DE HQ Wien, AT Gent, BE Sao Paulo, BR Beijing, CN Shanghai, CN Reims, FR see more	Locations Taizhou, CN HQ Riverside, US	Locations Maringá, BR HQ Aracaju, BR Brasilia, BR Cabedelo, BR Campo Grande, BR Contagem, BR Cuiabá, BR see more
Employees	Employees 59	Employees 2,200	Employees 1,800	Employees 1,693	Employees 1,586
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $717m (FY, 2022)	Revenue (est.) €249.9m (FY, 2021)	Revenue (est.) ¥1.1b (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €70.1m (FY, 2021)	Cost of goods ¥749.5m (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €179.7m (FY, 2021)	Gross profit ¥352.8m (FY, 2024)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income €4.1m (FY, 2021)	Net income ¥171.5m (FY, 2024)	Net income N/A